Commercialisation & licensing
Our IP&T experts have guided some of Australia's most successful technology companies from start-up to global success. We have extensive experience in licensing a range of technologies (patented and know-how) in Australia and around the world, including in China, Germany, India, Japan, Korea, South Africa, the UK and the USA.
Partner Rob McInnes is one of only a handful of private practice professionals in Australia to have met the requirements for the US-based Certified Licensing Professional qualification. Rob has also been ranked by Intellectual Asset Management Magazine in IAM Patent 1000: The World’s Leading Patent Practitioners, as both a recommended and highly recommended licensing lawyer in Australia since 2010.
Our team is able to assist you with:
- developing collaborative research and development agreements
- setting up ownership structures
- due diligence
- structuring and negotiating patent licensing
- commercialisation of technology and licensing
- IP strategy
- the acquisition and sale of intellectual property assets
- protection of technology and intellectual asset management
- IT contracts including outsourcing and service agreements
- franchising and distribution agreements
- commercialisation of plant varieties
- patent infringement and revocation proceedings
- training and educational seminars to ensure that a company is IP Ready and able to capitalise upon its valuable IP.
Licensing agreement for Progen Pharmaceuticals Ltd: We assisted Progen on their licence agreement with Medigen Biotechnology Corporation for the development and commercialisation of its drug candidate PG545 for the prevention and treatment for a certain type of liver cancer and non-oncology indications globally. Our assistance began at an early stage, providing Progen with strategic advice at the term-sheet stage regarding the structure of the deal, drafting the licensing agreement and assisting with the negotiations.
Licensing of vaccine technology from research institution for a listed client: We assisted our listed client in licensing a novel vaccine technology for dengue fever, vaccine technologies aimed at preventing hepatitis and influenza, and also in negotiating research agreements for the development of vaccine technology for eye conditions. Our work for this client has involved multiple transactions with public sector research organisations, liaison with academic researchers, and the successful management of stakeholder expectations.
Doyles Guide leading list rankings
Rob McInnes - Recommended Lawyer in Intellectual Property (Australia, 2016) and Preeminent Lawyer in Commercialisation IP (NSW, 2017)
DibbsBarker - Recommended Firm in Intellectual Property (Queensland, 2017), Second Tier Law Firm in Commercialisation & IP Transactions (Sydney, 2016) and Third Tier Law Firm in Intellectual Property (NSW, 2017)
Doyles Guide is an independent guide with rankings compiled through feedback from those in the legal profession.